首页|基于超高效液相色谱-四极杆飞行时间质谱和靶向网络药理学技术结合分子对接研究薤白治疗高血脂症的药效成分

基于超高效液相色谱-四极杆飞行时间质谱和靶向网络药理学技术结合分子对接研究薤白治疗高血脂症的药效成分

扫码查看
采用超高效液相色谱-四极杆飞行时间质谱(UPLC-Q-TOF-MS)技术快速分析了薤白中主要化学成分及入血成分,并根据相对分子质量、碎片离子以及色谱峰保留时间等信息对成分进行归属鉴定.在薤白药材中共鉴定出36种化学成分,包括28种皂苷类化合物、3种氨基酸类化合物、2种黄酮类化合物、1种有机硫化合物、1种核苷类化合物、1种类激素脂质化合物以及8种以原型入血的成分.基于入血成分与TCMSP平台数据库筛选交集成分,应用靶向网络药理学及分子对接技术,构建了"药物-成分-靶点-通路"关联网络,筛选出槲皮素、柚皮素、薤白苷E和25(R)-26-O-β-D-吡喃葡萄糖基-22-羟基-5β-呋甾3-O-β-D-吡喃葡萄糖基(1→2)-β-D-吡喃半乳糖苷为薤白药材治疗高血脂症的主要药效成分,磷酸腺苷活化蛋白激酶(AMPK)、肿瘤坏死因子(TNF)、血管内皮生长因子A(VEGFA)和基质金属蛋白酶9(MMP9)为薤白发挥降血脂药效的关键作用靶点.将主要药效成分与关键作用靶点进行分子对接,结果表明,4种药效成分均与AMPK结合较强,推测调节脂质代谢可能是薤白发挥降血脂作用的关键机制.本研究为研究薤白药效成分提供了数据参考,也为薤白药材质量标准的提升提供了依据.
Investigation of Pharmacodynamic Components of Allii Macrostemonis Bulbus in Treatment of Hyperlipidemia by Ultra-Performance Liquid Chromatography-Quadrupole Time-of-Flight Mass Spectrometry and Targeted Network Pharmacology Combined with Molecular Dockin
The main chemical components of Allii Macrostemonis Bulbus and components in serum were analyzed and identified rapidly and precisely by ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry(UPLC-Q-TOF-MS)technique in this study.The compounds were identified based on the relative molecular mass,fragmentation ions,and retention time of chromatographic peaks.A total of 36 kinds of chemical components were identified from Allii Macrostemonis Bulbus,including 28 kinds of saponins,3 kinds of amino acids,2 kinds of flavonoids,one kind of organosulfur compound,one kind of nucleoside,and one kind of hormone-lipid compound.In addition,8 kinds of compounds of Allii Macrostemonis Bulbus were identified from the serum.Based on the intersection compounds of which detected in serum and screened out by TCMSP platform database,by using targeted network pharmacology and molecular docking technology,a"drug-component-target-pathway"association network was constructed.Naringenin,quercetin,macrostemonoside E and 25(R)-26-O-β-D-glucopyranosyl-22-hydroxy-5β-furostan-3-O-β-D-glucopyranosyl(1→2)-β-D-glucopyranoside were screened as the main active constituents of Allii Macrostemonis Bulbus in the treatment of hyperlipidemia.In addition,adenosine 5′-monophosphate-activated protein kinase(AMPK),tumor necrosis factor(TNF),vascular endothelial growth factor A(VEGFA)and matrix metallopeptidase 9(MMP9)were the key action targets for Allii Macrostemonis Bulbus in the treatment of hyperlipidemia.Molecular docking was performed using the main pharmacodynamic components and key action targets.The results indicated that all the four active components showed strongly bound to AMPK.This suggested that the regulation of lipid metabolism might be the key mechanism of Allii Macrostemonis Bulbus in antihyperlipidemic effect.This study provided a data reference for the research on the pharmacodynamic components of Allii Macrostemonis Bulbus,and provided a basis for the improvement of quality standard of Allii Macrostemonis Bulbus.

Ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometryTargeted network pharmacologyMolecular dockingAllii Macrostemonis BulbusPharmacodynamic components

王一凯、董金旭、白玉涛、王瑞、黄鑫、陈长宝、越皓、刘侗、杨德辉

展开 >

长春中医药大学薤白研究所,长春 130117

吉林省东方制药有限公司,长春 130013

超高效液相色谱-四极杆飞行时间质谱 靶向网络药理学 分子对接 薤白 药效成分

吉林省科技发展计划

20210401073YY

2024

分析化学
中国化学会 中国科学院长春应用化学研究所

分析化学

CSTPCD北大核心
影响因子:1.423
ISSN:0253-3820
年,卷(期):2024.52(4)
  • 30